Best Meningioma doctors in Turkey: TOP 30 doctors

Dr. Solak completed a prestigious fellowship at Hacettepe University Cancer Institute, specializing in complex oncology cases.

• Graduated from Hacettepe University – one of Turkey's top medical schools
• Completed residency at İstanbul Sisli Etfal Teaching and Research Hospital
• Trained at MD Anderson Cancer Center in the US
• Specializes in breast and gastrointestinal cancers among others

Dr. Eda Tanrikulu specializes in medical oncology and chemotherapy at Anadolu Medical Center, focusing on complex cancer cases.

• Completed medical oncology training at Marmara University
• Ranked 3rd in Turkey in minor specialty exam
• Led medical oncology unit at Haydarpaşa Numune Training and Research Hospital
• Participated in international clinical studies

Prof. Kilic is the first Turkish doctor trained in radiosurgery at Sweden's Karolinska Institute – a pioneer in non-invasive brain tumor treatment.

• Highly specialized in Gamma Knife Radiosurgery for precise, non-surgical tumor targeting
• Holds a neuro-oncology research fellowship from Harvard Medical School and Dana-Farber Cancer Institute
• Member of the International Meningioma Society and World Federation of Neurosurgical Societies
• Former President of the Turkish Nervous System Surgery Society
• Professor and academic leader at Marmara University's Department of Neurosurgery

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Prof. Dr. Ahmet Hilmi Kaya is a professor of neurosurgery at Anadolu Medical Center in Gebze, Turkey. He earned his MD from Istanbul University Cerrahpaşa (English program). He completed his neurosurgery residency there from 1996 to 2003. He became a professor in 2015. He also completed observerships at Maastricht University in 2007 and 2009.

His clinical focus includes functional and stereotactic neurosurgery, including deep brain stimulation (DBS) for Parkinson’s disease and essential tremor. He also treats spinal tumors and spinal stenosis and performs spinal instrumentation. He manages skull base and brain tumors. He performs vascular surgery of the central nervous system.

Achievements include leading a Parkinson’s research project at Ondokuz Mayıs University (BAP, Project No. T.597, 2008). He supervised a neurosurgery thesis in 2008. His awards include third place at the 2nd National Congress of the Society of Neurosurgery in 2006, the Turkish Neurosurgical Society Overseas Scholarship in 2008, and the Aysima Altınok Thesis Award in 2009. Several of his papers ranked at the 22nd and 23rd Turkish Neurosurgical Society Scientific Congresses in 2008 and 2009. He is a member of the Turkish Neurosurgical Society and the Turkish Medical Association.

Prof. Sağlam is a professor specializing in gastrointestinal oncology at Gayrettepe Florence Nightingale Hospital.

• Completed medical oncology fellowship at Istanbul University
• Member of ESMO, ASCO, and European Neuroendocrine Tumor Society
• Has worked at American Cancer Center in Istanbul
• Specializes in both medical and gastrointestinal oncology

Specializing in meningioma treatment, Dr. Sakin brings extensive experience from leading hospitals including Medipol Bahçelievler Hospital.

• Head of Medical Oncology Department at Yüzüncü Yıl University
• Medical Oncology sub-specialty training at İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi
• Years of practical experience in oncology and internal medicine
• Active role in education and training within the medical field

Professor Doctor Sefik Igdem specializes in radiation oncology, focusing on precise treatments for meningioma at Gayrettepe Florence Nightingale Hospital.

• Board-certified in radiation oncology with extensive experience
• Uses advanced technologies like Truebeam Stx and Halcyons
• Former professor at T.R. Demiroğlu Bilim University
• Specializes in head and neck cancers

Dr. Sinan Karaaslan — Medical Oncologist at Anadolu Medical Center (since 2014). He treats breast, colorectal, and genitourinary cancers; in medical oncology since 2003. Member of the Turkish Medical Association, the Turkish Society of Medical Oncology, and the Turkish Lung Cancer Society.

Why patients choose and trust Dr. Karaaslan:

• Manages complex cases of breast, colorectal, and genitourinary cancers — applies modern systemic therapy tailored to the tumor type and stage.
• Member of the Turkish Medical Association, the Turkish Society of Medical Oncology, and the Turkish Lung Cancer Society.
• Author of numerous peer-reviewed articles and patient education materials on chemo- and immunotherapy.
• Practices at a center with ESMO Designated Centre status and JCI accreditation, within a strategic collaboration with Johns Hopkins Medicine International — one of the leading U.S. medical institutions. For patients, this means care aligned with U.S. protocols and the use of advanced equipment.

Specialist Dr. Rahib Hasanov brings international oncology expertise from training at Houston Methodist Hospital and Istanbul University.

• Completed Medical Oncology fellowship at Marmara University
• Specializes in personalized treatments using immunotherapies and targeted therapies
• Regularly treats international patients from Europe and the US

Professor in Medical Oncology with a focus on gastrointestinal tumors – Dr. Sezer Saglam combines academic rigor with clinical expertise at Florence Nightingale Hospital.

• Over 29 years of experience of experience in medical oncology
• Specialized in gastrointestinal oncology since 2009
• Member of ESMO, ASCO, and ENET societies
• Trained at Istanbul University – one of Turkey's leading medical institutions

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Dr. Yildiz specializes in neuroendocrine and rare tumors, with extensive research and clinical experience at Medipol Mega University Hospital.

• Published 17+ papers on neuroendocrine and rare tumors
• Expertise in diagnosing and managing complex tumor cases
• Active member of multiple international medical research studies

Associate Professor Tahsin Ozatli specializes in oncology with extensive experience across multiple cancer types, currently practicing at Istinye Liv University Hospital.

• Specializes in breast, lung, and gastrointestinal cancers
• Internal Medicine Specialist at Malatya State Hospital
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Studied medicine at Selcuk University

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Specialized in Medical Oncology with extensive training at Akdeniz University – Dr. Alemdar brings focused expertise to meningioma cases at Medical Park Antalya.

• Graduated from Kocaeli University Faculty of Medicine
• Completed Medical Oncology specialization in 2018
• Works at Medical Park Antalya Hospital Complex
• 20 years of experience of clinical experience

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Nail Paksoy brings specialized expertise in oncology to Medipol Bahçelievler Hospital, with a focus on targeted therapies.

• Over 15 years of experience of medical oncology fellowship training
• Active participant in international clinical trials for various cancers
• ESMO Board Certified in Medical Oncology
• Published multiple research papers on innovative cancer treatments
• Associate professor at Istanbul Medipol University

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.